Literature DB >> 35758259

6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patients.

Laure Ricard1,2, Déborah Eshagh1,3, Lama Siblany1,2, Frédéric de Vassoigne1,2, Florent Malard1,2, Charlotte Laurent1,3, Pauline Beurier1, Vincent Jachiet1,3, Sébastien Rivière3, Olivier Fain3, Mohamad Mohty1,2, Béatrice Gaugler1,2, Arsène Mekinian1,3.   

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis, microangiopathy, and autoantibodies. We previously reported that circulating follicular helper T (cTfh) cells are increased in SSc and induce plasmablast differentiation. However, mechanisms leading to cTfh cell expansion and activation in SSc remain to be established. Tfh cells require IL-12 for their expansion and differentiation. 6-Sulfo LacNAc monocytes (slanMo), a subset of monocytes, have a higher capacity to produce IL-12 and to induce CD4+ T cell proliferation in comparison with dendritic cells (DC) or classical monocytes. The aim of this study was to perform a quantitative and functional analysis of monocytes and DC and to correlate them with cTfh cell expansion and clinical manifestations in SSc. Using flow cytometry, we analyzed different monocyte subsets including slanMo and DC from 36 SSc patients and 26 healthy controls (HC). In vitro culture experiments of sorted slanMo were performed for functional analysis and cytokine production. We observed that slanMo, intermediate and non-classical monocytes were increased in SSc in comparison with HC. Furthermore, the increase in slanMo cells was more potent in patients with diffuse SSc. We observed a significant positive correlation between slanMo and cTfh cell levels in SSc patients but not in HC. Other monocyte subsets did not correlate with cTfh cell expansion. In addition, we observed that in vitro, slanMo cells from SSc patients produced less IL-12 than slanMo from HC. SlanMo are increased in SSc and may participate in the activation of cTfh cells in SSc.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  6; LacNAc monocytes; follicular helper T cells; sulfo; systemic sclerosis

Mesh:

Substances:

Year:  2022        PMID: 35758259      PMCID: PMC9390843          DOI: 10.1093/cei/uxac059

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  31 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Scleroderma.

Authors:  Armando Gabrielli; Enrico V Avvedimento; Thomas Krieg
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Circulating follicular helper T cells are increased in systemic sclerosis and promote plasmablast differentiation through the IL-21 pathway which can be inhibited by ruxolitinib.

Authors:  Béatrice Gaugler; Arsène Mekinian; Laure Ricard; Vincent Jachiet; Florent Malard; Yishan Ye; Nicolas Stocker; Sébastien Rivière; Patricia Senet; Jean-Benoit Monfort; Olivier Fain; Mohamad Mohty
Journal:  Ann Rheum Dis       Date:  2019-02-13       Impact factor: 19.103

4.  T follicular helper-like cells contribute to skin fibrosis.

Authors:  Devon K Taylor; Nanette Mittereder; Ellen Kuta; Tracy Delaney; Timothy Burwell; Karma Dacosta; Weiguang Zhao; Lily I Cheng; Charles Brown; Anmarie Boutrin; Xiang Guo; Wendy I White; Jie Zhu; Huifang Dong; Michael A Bowen; Jia Lin; Changshou Gao; Li Yu; Madhu Ramaswamy; Marie-Claude Gaudreau; Rob Woods; Ronald Herbst; Gianluca Carlesso
Journal:  Sci Transl Med       Date:  2018-03-07       Impact factor: 17.956

Review 5.  Dendritic cells in systemic sclerosis: Advances from human and mice studies.

Authors:  Alsya J Affandi; Tiago Carvalheiro; Timothy R D J Radstake; Wioleta Marut
Journal:  Immunol Lett       Date:  2017-11-07       Impact factor: 3.685

6.  Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.

Authors:  Marie Dominique Ah Kioon; Claudio Tripodo; David Fernandez; Kyriakos A Kirou; Robert F Spiera; Mary K Crow; Jessica K Gordon; Franck J Barrat
Journal:  Sci Transl Med       Date:  2018-01-10       Impact factor: 17.956

7.  Comparison of gene expression profiles between human and mouse monocyte subsets.

Authors:  Molly A Ingersoll; Rainer Spanbroek; Claudio Lottaz; Emmanuel L Gautier; Marion Frankenberger; Reinhard Hoffmann; Roland Lang; Muzlifah Haniffa; Matthew Collin; Frank Tacke; Andreas J R Habenicht; Loems Ziegler-Heitbrock; Gwendalyn J Randolph
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

8.  Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.

Authors:  Takashi Matsushita; Minoru Hasegawa; Yasuhito Hamaguchi; Kazuhiko Takehara; Shinichi Sato
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

9.  Early commitment of naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12.

Authors:  Cindy S Ma; Santi Suryani; Danielle T Avery; Anna Chan; Ralph Nanan; Brigitte Santner-Nanan; Elissa K Deenick; Stuart G Tangye
Journal:  Immunol Cell Biol       Date:  2009-09-01       Impact factor: 5.126

10.  Flow cytometry evaluation of CD14/CD16 monocyte subpopulations in systemic sclerosis patients: a cross sectional controlled study.

Authors:  Laiana Schneider; Natália Aydos Marcondes; Vanessa Hax; Isadora Flesch da Silva Moreira; Carolina Yuka Ueda; Rafaella Romeiro Piovesan; Ricardo Xavier; Rafael Chakr
Journal:  Adv Rheumatol       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.